These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3794875)

  • 1. Enhancement of linear growth and weight gain by cyproheptadine in children with hypopituitarism receiving growth hormone therapy.
    Kaplowitz PB; Jennings S
    J Pediatr; 1987 Jan; 110(1):140-3. PubMed ID: 3794875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
    Cara JF; Kreiter ML; Rosenfield RL
    J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel treatment for height growth in patients with growth hormone insensitivity syndrome by cyproheptadine hydrochloride.
    Razzaghy-Azar M; Nourbakhsh M; Nourbakhsh M
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):880-888. PubMed ID: 29520979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative importance of growth hormone and sex steroids for the growth at puberty of trunk length, limb length, and muscle width in growth hormone-deficient children.
    Tanner JM; Whitehouse RH; Hughes PC; Carter BS
    J Pediatr; 1976 Dec; 89(6):1000-8. PubMed ID: 993900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of growth and somatomedin C responses following growth hormone treatment in children with small-for-date short stature, significant idiopathic short stature and hypopituitarism.
    Grunt JA; Howard CP; Daughaday WH
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):168-74. PubMed ID: 6539552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L; Karachaliou F; Neou P; Papataxiarchou K; Pistevos G; Bartsocas CS
    Am J Med Genet; 1997 Oct; 72(1):71-6. PubMed ID: 9295079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal characteristics and first year responses to human growth hormone (GH) vary according to diagnostic criteria in children with non-acquired GH deficiency (naGHD): observations from a single center over a period of five decades.
    Ranke MB; Schweizer R; Binder G
    J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1257-1266. PubMed ID: 30332395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of growth hormone-deficient children to human growth hormone. Effect of replacement therapy for one year.
    Rudman D; Patterson JH; Gibbas DL
    J Clin Invest; 1973 May; 52(5):1108-12. PubMed ID: 4700485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal handling of phosphate can predict height velocity during growth hormone therapy for short children.
    Nishiyama S; Ikuta M; Nakamura T; Tomoeda S; Matsuda I
    J Clin Endocrinol Metab; 1992 Apr; 74(4):906-9. PubMed ID: 1548358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term growth response to GH treatment and considerations upon the limits of short-term growth predictions.
    Hermanussen M; Gausche R; Keller A; Kiess W; Brabec M; Keller E
    Horm Res; 2002; 58(2):71-7. PubMed ID: 12207165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nightly clonidine administration on growth velocity in short children without growth hormone deficiency: a double-blind, placebo-controlled study.
    Allen DB
    J Pediatr; 1993 Jan; 122(1):32-6. PubMed ID: 8419612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).
    Geffner M; Lundberg M; Koltowska-Häggström M; Abs R; Verhelst J; Erfurth EM; Kendall-Taylor P; Price DA; Jonsson P; Bakker B
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5435-40. PubMed ID: 15531494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan's syndrome.
    Cotterill AM; McKenna WJ; Brady AF; Sharland M; Elsawi M; Yamada M; Camacho-Hübner C; Kelnar CJ; Dunger DB; Patton MA; Savage MO
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2291-7. PubMed ID: 8964866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catch-up growth and height prognosis in early treated children with congenital hypopituitarism.
    Arrigo T; De Luca F; Bernasconi S; Bozzola M; Cavallo L; Crisafulli G; Ghizzoni L; Maghnie M; Zecchino C
    Horm Res; 1995; 44 Suppl 3():26-31. PubMed ID: 8719437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
    Quintos JB; Vogiatzi MG; Harbison MD; New MI
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Wit JM; Wolff ED; de Jong MC; Donckerwolcke RA; Abbad NC; Bot A; Blum WF
    Lancet; 1991 Sep; 338(8767):585-90. PubMed ID: 1715501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A; Simon D; Czernichow P
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.